Search Results for "Medical Advances By 2020"
Matching Channels
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of whi...
Devices - medical, biotech, pharma
A medical device is a product which is used for medical purposes in patients, in diagnosis, therapy or surgery. Medical devices act by physical, mechanical, thermal, physico-chemical or chemic...
The Top 10 Medical Device Companies
Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...
Maryland, the US state on the mid-Atlantic coast, is hub of biotechnology institutions and companies. In 2005/2006 is was the 2nd best area globally for initiatives aimed at drawing and retaining bi...
Matching News
BRAIN to lead the NatLifE 2020 industrial innovation alliance
BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance will be funded by the Federal Ministry of Education and Research (BMBF) under the “Industrial...
UPDATE 1-Somaxon keeps insomnia drug exclusivity till 2020
* Grants Mylan right to sell generic Silenor from January 2020
Half Of Britons Will Have Cancer During Their Lifetime By 2020
According to Macmillan Cancer Support, by 2020, nearly half of the people in the UK will get cancer in their lifetime, a statistic that poses what the UK charity describes as a "herculean" challenge...
BRAIN-led industrial NatLifE 2020 innovation alliance started after receipt of approval
As the industrial coordinator of the innovation alliance, the biotechnology company BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance is the first...
Half of UK will get cancer in their lifetime by 2020
In 2020 almost one in two people (47%) will get cancer in their lifetime, but almost four in 10 (38%)1 will not die from the disease, according to new projections from Macmillan Cancer Support. The c...
“Horizon 2020″ – Karlheinz Töchterle: Mehr Forschung, weniger Bürokratie
Wissenschafts- und Forschungsminister beim Rat Wettbewerbsfähigkeit in Luxemburg Wien (OTS) – Wissenschafts- und Forschungsminister Dr. Karlheinz Töchterle nimmt heute am Rat Wettbewerbsfähi...
Diabetes in 2025: Can Advances Keep Pace With Prevalence?
The future of diabetes care involves exciting advances in technology, biology, and pharmacology. Therapeutic Advances in Endocrinology and Metabolism
WHO says Cambodia can end HIV infections by 2020
Cambodia is on track to become one of the few countries in the world to successfully reverse its HIV epidemic and may eliminate new infections by 2020, the World Health Organization said Friday.
Matching PubMed Articles
OBJECTIVE: To identify the responsible mutation of autosomal dominant polycystic kidney disease (ADPKD) in two Chinese families. METHODS: Total genomic DNA of all available family members and 100 unr...
Technology for mobility in SCI 10 years from now.
Objectives:To identify technological advances and that are likely to have a great impact on the quality of life and participation in individuals with spinal cord injury (SCI).Methods:In this paper we...
Physical activity levels of high school students --- United States, 2010.
Healthy People 2020 (HP 2020), released in December 2010, outlines numerous public health objectives, including objectives for youth physical activity participation (1). HP 2020 includes three objecti...
Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.
This article describes the adaptation of a model assessing the incidence of osteoporotic fractures and prevalence of postmenopausal osteoporosis (PMO) in Germany. PURPOSE: The purpose of this paper is...
